bevacizumab
roche
[]
 i think that this a subset that if you continue to not just select or hyper-select, but like ultra-hyper-select, &amp; continue to refine the ones who would benefit the most, you could really the overall survival. and spare the toxicity to those who don t need it. #gi23 
Oncologist | Researcher | ColorectalCancer #CRCSM👨🏼‍🎓@MayoClinic @PittTweet Alum; 🧬#ctDNA #LiquidBiopsies💡#PrecisionOncology ViewsMy Own. COI @ASCO📍 #GI23